Morgan Stanley reduced UnitedHealth Group’s price target to $325 from $342 on August 20, maintaining an Overweight rating due to a longer turnaround timeline. The firm suggested potential upside to current EPS expectations but highlighted uncertainties related to Medicare Star ratings and regulatory changes.

UnitedHealth Group offers health benefits, care services, and data solutions to various customers. Cramer mentioned on August 13 that the company has potential for a comeback, despite past issues.

While UnitedHealth Group shows investment potential, some AI stocks may offer greater upside with less risk. Consider exploring undervalued AI stocks for potential benefits from tariffs and onshoring trends.

For more stock insights, check out “30 Stocks That Should Double in 3 Years” and “11 Hidden AI Stocks to Buy Right Now.”

Disclosure: None. Source: Insider Monkey.

Read more at Yahoo Finance: Morgan Stanley Lowers United Health Price Target to $325, Maintains Overweight